Indaptus Therapeutics, Inc. (INDP) income statement
INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.82−0.31 (-9.90%)
Close on Nov 20, 2026Market cap $375.74MP/E –Yield –
Indaptus Therapeutics, Inc. financial ratios
See a number that looks wrong?